Jennison Associates’s GenMark Diagnostics, Inc GNMK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | – | Sell |
-105,960
| Closed | -$676K | – | 719 |
|
|
2018
Q2 | $676K | Sell |
105,960
-86,248
| -45% | -$550K | ﹤0.01% | 591 |
|
|
2018
Q1 | $1.05M | Sell |
192,208
-1,523,556
| -89% | -$8.29M | ﹤0.01% | 557 |
|
|
2017
Q4 | $7.16M | Sell |
1,715,764
-1,851,237
| -52% | -$7.72M | 0.01% | 479 |
|
|
2017
Q3 | $34.4M | Buy |
3,567,001
+25,254
| +0.7% | +$243K | 0.04% | 322 |
|
|
2017
Q2 | $41.9M | Buy |
3,541,747
+443,005
| +14% | +$5.24M | 0.04% | 290 |
|
|
2017
Q1 | $39.7M | Sell |
3,098,742
-123,974
| -4% | -$1.59M | 0.04% | 309 |
|
|
2016
Q4 | $39.4M | Buy |
3,222,716
+342,213
| +12% | +$4.19M | 0.04% | 306 |
|
|
2016
Q3 | $34M | Sell |
2,880,503
-173,237
| -6% | -$2.04M | 0.04% | 335 |
|
|
2016
Q2 | $26.6M | Sell |
3,053,740
-170,854
| -5% | -$1.49M | 0.03% | 367 |
|
|
2016
Q1 | $17M | Buy |
3,224,594
+80,160
| +3% | +$422K | 0.02% | 422 |
|
|
2015
Q4 | $24.4M | Buy |
3,144,434
+214,822
| +7% | +$1.67M | 0.02% | 393 |
|
|
2015
Q3 | $23.1M | Sell |
2,929,612
-80,213
| -3% | -$631K | 0.02% | 411 |
|
|
2015
Q2 | $27.3M | Sell |
3,009,825
-669,492
| -18% | -$6.07M | 0.03% | 425 |
|
|
2015
Q1 | $47.8M | Sell |
3,679,317
-19,731
| -0.5% | -$256K | 0.04% | 333 |
|
|
2014
Q4 | $50.3M | Sell |
3,699,048
-62,085
| -2% | -$845K | 0.05% | 328 |
|
|
2014
Q3 | $33.7M | Buy |
3,761,133
+86,581
| +2% | +$777K | 0.03% | 386 |
|
|
2014
Q2 | $49.7M | Sell |
3,674,552
-410,013
| -10% | -$5.55M | 0.05% | 331 |
|
|
2014
Q1 | $40.6M | Sell |
4,084,565
-24,111
| -0.6% | -$240K | 0.04% | 355 |
|
|
2013
Q4 | $54.7M | Sell |
4,108,676
-112,946
| -3% | -$1.5M | 0.05% | 289 |
|
|
2013
Q3 | $51.3M | Buy |
4,221,622
+540,899
| +15% | +$6.57M | 0.05% | 296 |
|
|
2013
Q2 | $38.1M | Buy |
+3,680,723
| New | +$38.1M | 0.04% | 329 |
|